152 Afleveringen

  1. Medical Affairs Series, Part Five: Medical Affairs in the Early Stage

    Gepubliceerd: 10-1-2020
  2. Real World Evidence and Rare Diseases

    Gepubliceerd: 20-12-2019
  3. The Digital Therapeutics Alliance: A European Perspective

    Gepubliceerd: 11-12-2019
  4. Medical Affairs Series, Part Four: Medical Affairs in the Field

    Gepubliceerd: 20-11-2019
  5. Medical Affairs Series, Part Three: Moving to the Left

    Gepubliceerd: 6-11-2019
  6. Advocacy Archetypes

    Gepubliceerd: 24-10-2019
  7. Medical Affairs Series, Part Two - Measuring the Unmeasurable: Medical Affairs Metrics

    Gepubliceerd: 9-10-2019
  8. Why We Resist

    Gepubliceerd: 25-9-2019
  9. Medical Affairs Series, Part One: A Foundation for Medical Affairs

    Gepubliceerd: 11-9-2019
  10. A Regulatory Roadmap for Real World Evidence

    Gepubliceerd: 28-8-2019
  11. Talented Teams

    Gepubliceerd: 14-8-2019
  12. Digital Therapeutics

    Gepubliceerd: 31-7-2019
  13. Talking About PIE

    Gepubliceerd: 17-7-2019
  14. MOAs in ONC: The Latest and Greatest in the Oncology Pipeline

    Gepubliceerd: 3-7-2019
  15. Episode 037: Psychology in Clinical Trials

    Gepubliceerd: 19-6-2019
  16. Episode 036: Commercialization for Emerging Companies

    Gepubliceerd: 5-6-2019
  17. Episode 035: How Translational Science Can Solve Pharma's Productivity Puzzle

    Gepubliceerd: 15-5-2019
  18. Episode 034: Can the Gut Microbiome Revolutionize Medical Care?

    Gepubliceerd: 1-5-2019
  19. APAC Edition: Medical Affairs in China

    Gepubliceerd: 26-4-2019
  20. Episode 033: From DTC to DT"Me" - The Future of Communications in Pharmaceuticals

    Gepubliceerd: 17-4-2019

6 / 8

The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.

Visit the podcast's native language site